Chugai Pharmabody

Global Chugai News Release

Monday, 9 December 2019 9:00 AM

Chugai’s Nemolizumab Receives FDA Breakthrough Therapy Designation for the Treatment of Pruritus Associated with Prurigo Nodularis

Friday, 6 December 2019 4:30 AM

“Let’s Learn about Cancer Genomic Medicine,” Chugai’s Website for Patients and the General Public, Won the Asakawa Award in the 7th Web GRAND PRIX

Wednesday, 4 December 2019 6:00 AM

R&I Raises Chugai's Issuer Rating from “AA –” to “AA”